Clear answers before a serious conversation

StrategicRX is designed for established growth companies with proven demand, active customers, and a functioning commercial team. The strongest fit is a multi-market, high-volume, or recurring-revenue business with meaningful customer data.

A strong fit exists when revenue performance is weaker than expected and the cause crosses several teams. Common examples include weak conversion, margin pressure, poor handoffs, or uneven execution across markets.

No. StrategicRX does not provide branding, demand generation, or outsourced prospecting. We enter after demand exists and focus on conversion, revenue productivity, customer value, and the operating conditions behind them.

The scope can begin with the first customer response and continue through sales, onboarding, retention, and expansion. We focus only on the stages where the evidence shows material value is being lost.

We select the few measures that explain the business issue. These often include conversion, sales productivity, margin, customer retention, and expansion value.

No. The plan is the right start when the causes or priorities are unclear. A company with agreed priorities may move directly into 90-Day Commercial Acceleration. The Executive Decision Program is a separate, one-on-one path for one major decision.

Over 10 to 15 business days, we establish what is happening and why. Chris then designs the solutions with leadership and turns them into a prioritized action plan with clear owners.

The company can move into 90-Day Commercial Acceleration, led by Chris with the internal team. After the 90-day build, guided execution can continue while senior support is useful.

It is hands-on implementation of the agreed priorities. Chris leads the work across the teams, customer journey, decisions, and tools involved in the change.

The Executive Decision Program is a private, one-on-one engagement. Across four structured sessions, Chris helps one senior leader define the decision, test assumptions, compare options, and establish a clear path. It can run separately or alongside commercial work.

StrategicRX needs an executive sponsor, access to the business, timely decisions, and an internal owner who can support implementation.

Slow decisions, limited access, or unclear ownership can delay execution. In that case, we narrow the scope or extend the timeline before continuing.

No. The standard engagement is designed to build and enable the required commercial changes. If the company wants Chris to run a function or hold an ongoing executive role, that requires a separate scope and price.

No fixed percentage can be guaranteed. Results depend on the baseline, market, decisions, adoption, and internal execution. StrategicRX commits to the agreed diagnosis, solution design, measurement, and implementation responsibilities.

Scope and investment depend on the size and complexity of the business issue, the work required, and the level of implementation support. Outcomes, responsibilities, timing, and commercial terms are agreed before work begins.